T-Cypher Bio extends footprint in purpose-built laboratory space at Abingdon Science Park, Oxford

by rss feed | Nov 11, 2026 | News Feeds

T-Cypher Bio ("T-Cypher), a biotechnology company developing novel T cell receptor (TCR)-based T cell engagers that target high copy number antigens, today announced its relocation to Abingdon Science Park, Oxford, UK. Read Original...

Mogrify to present preclinical proof-of-concept data for first-in-class retinal in vivo reprogramming therapy

by rss feed | Nov 11, 2026 | News Feeds

Mogrify Limited (Mogrify®), a regenerative medicine company developing a novel class of in vivo reprogramming therapies, today announced it will present preclinical proof-of-concept data at FLORetina-ICOOR 2026. Read Original...

Omega-3 supplements show surprising effects on blood pressure

by rss feed | Nov 11, 2026 | News Feeds

Findings suggest omega-3 supplements improve blood pressure and inflammatory biomarkers in hypertensive patients, indicating potential therapeutic benefits. Read Original...

L.B. Bohle will be showcasing productive, energy-efficient and scalable OSD solutions at PMEC India 2026

by rss feed | Nov 11, 2026 | News Feeds

The challenge for India’s pharmaceutical manufacturers is clear: How to reliably scale production, reduce energy costs, and safeguard operators – all at once. From November 24 to 26, 2026, L.B. Bohle will present these solutions at stand 9C02 in the India Expo Centre...

Job-search app boosts employment rates and reduces depressive symptoms

by rss feed | Nov 11, 2026 | News Feeds

Losing a job can be a life-shattering experience. And when depression complicates a job search, unemployment can become a vicious cycle. Read Original...

EU-funded project develops mRNA vaccine targeting liver cancer

by rss feed | Nov 11, 2026 | News Feeds

The European Innovation Council (EIC) is providing approximately €3.8 million in funding for the international research project ADVANCE, in which Universitätsmedizin Frankfurt is participating. The ADVANCE research team aims to develop an mRNA-based cancer vaccine for...